StemCyte International, Ltd. (TPEX:4178)
24.50
-0.70 (-2.78%)
At close: Sep 19, 2025
StemCyte International Revenue
StemCyte International had revenue of 197.31M TWD in the half year ending June 30, 2025, with 10.24% growth. This brings the company's revenue in the last twelve months to 398.60M, up 9.15% year-over-year. In the year 2024, StemCyte International had annual revenue of 382.69M with 5.49% growth.
Revenue (ttm)
398.60M
Revenue Growth
+9.15%
P/S Ratio
11.81
Revenue / Employee
n/a
Employees
n/a
Market Cap
4.71B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 382.69M | 19.91M | 5.49% |
Dec 31, 2023 | 362.78M | 15.09M | 4.34% |
Dec 31, 2022 | 347.69M | -509.38M | -59.43% |
Dec 31, 2013 | 857.07M | 124.33M | 16.97% |
Dec 31, 2012 | 732.74M | 205.09M | 38.87% |
Dec 31, 2011 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Taiwan Semiconductor Manufacturing Company | 3,401.20B |
Hon Hai Precision Industry | 7,422.86B |
Delta Electronics | 469.36B |
MediaTek | 573.54B |
Fubon Financial Holding | 814.41B |
Quanta Computer | 1,831.66B |
Chunghwa Telecom | 233.45B |
Cathay Financial Holding | 1,168.47B |